Table 1.
Prospective noncontrolled response-adapted studies in adult early-stage (I-II) HL
SCT, stem cell transplantation; and NA, not available.
* Biopsy done if PET-4 is positive; patients receive same therapy as PET-4− for negative biopsy and salvage therapy for positive PET-4 biopsy.
†Enrollment as of June 2014. Of enrolled patients, 173 have early-stage disease.
